| Value | ₹0.90 Cr |
|---|
BSE filing, NSE: ALIVUS. Summary written from the filing by ALFA Finder's alert engine.
Alivus Life Sciences Ltd: key numbers
- Share price
- ₹1,393.90
- Market cap
- ₹17,113 Cr
- Revenue (annual)
- ₹2,552 Cr
- Net profit (annual)
- ₹564.5 Cr
- P/E (TTM)
- 28.4×Sector 46.1×
- Promoter holding
- 74.85%-0.02% QoQ
- FII holding
- 5.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alivus Life Sciences Ltd
All →Alivus Life Sciences Board Meeting Date
Alivus Life Sciences Ltd has scheduled a Board Meeting on October 29, 2026, to consider and approve its unaudited financial results for the period ended September 30, 2026.
Alivus Life Sciences Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Alivus Life Sciences Legal & Regulatory
Alivus Life Sciences Limited received a GST order for FY 2020-22 involving a tax demand and penalty of Rs. 0.51 Crore. The company is currently assessing an appeal.
- Value
- ₹0.51 Cr
Alivus Life Sciences Acquisition Worth ₹14.04 Cr
Alivus Life Sciences acquired a 9.21% stake in Torrent Urja 19 Private Limited for Rs. 14.04 Crore. The investment supports its renewable energy and carbon neutrality goals.
- Value
- ₹14.04 Cr
Alivus Life Sciences Annual General Meeting
Alivus Life Sciences Limited successfully conducted its 15th Annual General Meeting on September 8, 2026. All resolutions proposed in the AGM notice were passed with requisite majority.
Alivus Life Sciences Merger & Restructuring Worth ₹9.12 Cr
Alivus Life Sciences Limited will acquire a 76% stake in IQGEN-X Pharma Private Limited for approximately ₹9.12 Crore. This strategic acquisition enhances the company's CDMO solution offerings.
- Value
- ₹9.12 Cr
Other merger & restructuring announcements
All →Praj Industries Merger & Restructuring Worth ₹100 Cr
Praj Industries' board approved in-principle investment of up to ₹100 crore in a joint venture with BPCL. The JV will set up compressed biogas plants across India.
- Value
- ₹100.0 Cr
Dollex Agrotech Merger & Restructuring Worth ₹0.01 Cr
DOLLEX AGROTECH LIMITED will hold a 99.99% stake in newly incorporated wholly owned subsidiary Dollex Green Ventures Private Limited via cash subscription. The entity targets renewable energy, biogas and bio-fertilizers.
- Value
- ₹0.01 Cr
Dollex Agrotech Merger & Restructuring
Dollex Agrotech incorporated wholly owned subsidiary Dollex Green Ventures on 28 Oct 2026. It will pursue biogas, Bio-CNG and renewable energy; no investment amount is disclosed.
GK Energy Merger & Restructuring
GK Energy's board approved incorporating five wholly-owned BESS subsidiaries in the energy sector. All will be 100% owned and subscribed at face value.
Raghav Productivity Enhancers Merger & Restructuring
RPEL acquired 80% of JV entity RPEL TRLK Silicatech Pvt Ltd for Rs. 80,000. The Odisha-based entity will manufacture silica ramming mass and refractories.
Mohite Industries Merger & Restructuring
Mohite Industries seeks postal ballot approval to sell its spinning unit land and plant to unidentified buyers, and to shift registered office. E-voting closes 29 November 2026.